Home | Business News | Browse by Publication | B | Biotech Week

Bristol-Myers Squibb Company Announces Sale to Taisho Pharmaceutical Co Ltd., of Its OTC Assets in Asia Pacific Excl. China & Japan and Shares in PT Bristol-Myers Squibb Indonesia Tbk.

Publication: Biotech Week
Publication Date: 30-SEP-09
Format: Online
Delivery: Immediate Online Access

Article Excerpt
Bristol-Myers Squibb Company (NYSE: BMY) announced that it has reached an agreement for the sale of its OTC assets in Asia Pacific (excluding China and Japan) to Taisho Pharmaceutical Co., Ltd. ("Taisho") (see also Bristol-Myers Squibb Company).

Pursuant to the terms of the definitive agreement, Taisho will acquire from Bristol-Myers Squibb...

View this article FREE - Now for a Limited Time, try Goliath Business News
Free for 3 Days!



More articles from Biotech Week
Bristol-Myers Squibb to Present at Morgan Stanley Global Healthcare Un..., September 30, 2009
Broadcom Sues Emulex for Patent Infringement., September 30, 2009
Limbach Laboratory Network Group Selects Bruker[acute accent]s MALDI B..., September 30, 2009
GENova Biotherapeutics GVBP SqueezeTrigger Price is $0.43. Approximate..., September 30, 2009
California Stem Cell and Stemina Biomarker Discovery Announce Collabor..., September 30, 2009

Looking for additional articles?
Search our database of over 3 million articles.

Looking for more in-depth information on this industry?
Search our complete database of Industry & Market reports by text, subject, publication name or publication date.

About Goliath
Whether you're looking for sales prospects, competitive information, company analysis or best practices in managing your organization, Goliath can help you meet your business needs.

Our extensive business information databases empower business professionals with both the breadth and depth of credible, authoritative information they need to support their business goals. Whether it be strategic planning, sales prospecting, company research or defining management best practices - Goliath is your leading source for accurate information.